Sirtex Medical is a global healthcare business with offices in the US, Australia, Germany and Singapore, working to improve outcomes in people with cancer. Sirtex’ current lead product is SIR-Spheres® Y-90 resin microspheres, a medical device used in Selective Internal Radiation Therapy (SIRT) for treatment of primary and secondary liver tumors. Sirtex also distributes EmboCept® S DSM 50 μm, Degradable Starch Microspheres (DSM) used as adjuvant in the intra-arterial treatment of inoperable liver tumours and lung tumours in combination with cytostatic agents. For further information please visit www.sirtex.com. SIR-Spheres® is a registered trademark of Sirtex SIR-Spheres Pty Ltd EmboCept® is a registered trademark of Magle PharmaCept GmbH